Parkin, Georgia M.
Kim, Soyun
Mikhail, Abanoub
Malhas, Rond
McMillan, Liv
Hollearn, Martina
Granger, Douglas A.
Mapstone, Mark
Yassa, Michael A.
Thomas, Elizabeth A. http://orcid.org/0000-0002-2024-4710
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01AG53555, R21NS111655)
Article History
Received: 25 July 2022
Accepted: 20 October 2022
First Online: 1 November 2022
Declarations
:
: Doug Granger is founder and majority equity holder of Salimetrics LLC and Salivabio LLC. He serves as the Chief Scientific and Strategy Advisor at these companies. These relationships are managed by the policies of the committees on conflict of interest at the Johns Hopkins University School of Medicine and University of California at Irvine. Mark Mapstone is an inventor on patents assigned to Georgetown University, the University of Rochester and the National Institutes of Health. The terms of this arrangement have been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies. Remaining authors declare no competing financial interests.
: This study was approved by the University of California, Irvine, Institutional Review Board, in accordance with the requirements of the Code of Federal Regulations on the Protection of Human Subjects.
: All participants gave written informed consent prior to sample collection, which was done at the baseline visit.